The figure also showed broad peaks at 1030 cm!1 and 1080 cm 1 corresponding to the C-O stretching vibration and other peaks around 893 cm!1 and 1156 cm !1 corresponding to saccharide (III as the concentration of chitosan increase ,as polymer tend to trap the drug & used to release drug in sustained fasion, only 23% of the drug release in initial 3 minutes
KPV: Best for inflammatory pain and conditions Why KPV is superior for inflammation: Extremely potent anti-inflammatory peptide Reduces IL-6, TNF-alpha, other inflammatory markers Modulates immune response Works systemically Best for: Rheumatoid arthritis Autoimmune-related pain Inflammatory bowel disease with pain Chronic systemic inflammation Widespread pain from inflammation Dosing: Injectable: 500-1,000mcg daily subcutaneous Oral: 1-2mg daily for gut-specific inflammation 8-12 weeks minimum Can use long-term Expected results: Week 2-4: Reduced inflammatory markers Week 4-8: Decreased pain levels Week 8-12: Significant inflammation control Comparison to NSAIDs: KPV: Reduces inflammation without stomach damage NSAIDs: Temporary relief, stomach/kidney risks KPV safer long-term BPC-157 for inflammation + tissue healing Why BPC-157 for inflammatory pain: Anti-inflammatory effects Also heals tissue causing inflammation Dual benefit Best for: Inflammatory pain with tissue damage IBD/Crohn's (gut inflammation) General inflammatory conditions Can combine KPV + BPC-157: KPV: Powerful inflammation reduction BPC-157: Tissue healing Together = comprehensive inflammatory pain relief Best peptide for chronic widespread pain Fibromyalgia, chronic pain syndrome, multi-site pain
Studies show that CGRP levels increase in patients with fractures
6 Egrifta Medication Guide / NCBI BookshelfCommon adverse effects, contraindications (active malignancy, pregnancy, mannitol hypersensitivity), IGF-1 monitoring and site rotation
